
Anders Bue Klein
@bueklein
CEO, Ousia Pharma
ID: 1201362930111012865
02-12-2019 04:51:20
8 Tweet
144 Followers
161 Following


Curious about the role of GDF15 in energy metabolism and exercise motivation? Check out this new preprint from our lab, led by: Anders Bue Klein and Trine Sand Nicolaisen biorxiv.org/content/10.110… NNF Center for Basic Metabolic Research (CBMR) Københavns Uni


Excited to be presenting our work on GDF15 in energy metabolism tonight at Keystone Symposia #VKSDiabetes21 #VKSObesity21 NNF Center for Basic Metabolic Research (CBMR) Københavns Uni

Check out our work regarding antidepressant mechanisms in this preprint. Samuel Kohtala and others biorxiv.org/cgi/content/sh…

(1/9) New paper out in Translational Psychiatry in which we do a deep dive pre-clinical evaluation of the psychedelic, psilocybin, for obesity treatment. Credit to PhD candidate Nicole Fadahunsi + several lab members for excellent execution. Open access: nature.com/articles/s4139…

In session 2 we had incredible talks from Ousia Pharma CSO Anders Klein Anders Bue Klein, Bayer | Pharmaceuticals representative Peter Sandner and SPARK programme director Ditte Riber about their very rich careers and what steps we need to take to work with/in Industry and for commercialisation
